Europe Neurorehabilitation Devices Market
The Europe Neurorehabilitation Devices Market size was valued at US$ 631.51 Mn in 2023 and is projected to reach US$ 1,509.96 Mn by 2031, growing at a CAGR of 11.5% during 2023 - 2031.
Report Coverage
- Product Type: Neurorobotic System, Brain Computer Interface, Non-invasive Stimulators, Wearable Devices
- Application: Stroke, Traumatic Brain Injury, Spinal Cord Injury, Parkinson\'s Disease, Cerebral Palsy
- End User: Rehabilitation Centers, Hospitals and Clinics, Home Care
US$ 631.51 Mn
Market size in 2023
US$ 1,509.96 Mn
Market Size by 2031
11.5%
CAGR, 2023 - 2031
2024-2031
Forecast Period
1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Europe Neurorehabilitation Devices Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Europe Neurorehabilitation Devices Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Europe Neurorehabilitation Devices Market Regional Analysis
6.2 Europe Neurorehabilitation Devices Market Revenue 2021-2031 (US$ Million)
6.3 Europe Neurorehabilitation Devices Market Forecast Analysis
7. Europe Neurorehabilitation Devices Market Analysis – by Product Type
7.1 Neurorobotic System
- 7.1.1 Overview
- 7.1.2 Neurorobotic System: Europe Neurorehabilitation Devices Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.2 Brain Computer Interface
- 7.2.1 Overview
- 7.2.2 Brain Computer Interface: Europe Neurorehabilitation Devices Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.3 Non-invasive Stimulators
- 7.3.1 Overview
- 7.3.2 Non-invasive Stimulators: Europe Neurorehabilitation Devices Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.4 Wearable Devices
- 7.4.1 Overview
- 7.4.2 Wearable Devices: Europe Neurorehabilitation Devices Market – Revenue and Forecast, 2021-2031 (US$ Million)
8. Europe Neurorehabilitation Devices Market Analysis – by Application
8.1 Stroke
- 8.1.1 Overview
- 8.1.2 Stroke: Europe Neurorehabilitation Devices Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.2 Traumatic Brain Injury
- 8.2.1 Overview
- 8.2.2 Traumatic Brain Injury: Europe Neurorehabilitation Devices Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.3 Spinal Cord Injury
- 8.3.1 Overview
- 8.3.2 Spinal Cord Injury: Europe Neurorehabilitation Devices Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.4 Parkinson\'s Disease
- 8.4.1 Overview
- 8.4.2 Parkinson\'s Disease: Europe Neurorehabilitation Devices Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.5 Cerebral Palsy
- 8.5.1 Overview
- 8.5.2 Cerebral Palsy: Europe Neurorehabilitation Devices Market – Revenue and Forecast, 2021-2031 (US$ Million)
9. Europe Neurorehabilitation Devices Market Analysis – by End User
9.1 Rehabilitation Centers
- 9.1.1 Overview
- 9.1.2 Rehabilitation Centers: Europe Neurorehabilitation Devices Market – Revenue and Forecast, 2021-2031 (US$ Million)
9.2 Hospitals and Clinics
- 9.2.1 Overview
- 9.2.2 Hospitals and Clinics: Europe Neurorehabilitation Devices Market – Revenue and Forecast, 2021-2031 (US$ Million)
9.3 Home Care
- 9.3.1 Overview
- 9.3.2 Home Care: Europe Neurorehabilitation Devices Market – Revenue and Forecast, 2021-2031 (US$ Million)
10. Europe Neurorehabilitation Devices Market – Europe Analysis
10.1 Overview
10.2 Europe- 10.2.1 Europe Neurorehabilitation Devices Market Breakdown, by Key Country, 2024 and 2031 (%)
- 10.2.1.1 Europe Neurorehabilitation Devices Market – Revenue and Forecast Analysis – by Country
- 10.2.1.1 UK: Europe Neurorehabilitation Devices Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.1.1 UK: Europe Neurorehabilitation Devices Market Breakdown, by Product Type
- 10.2.1.1.2 UK: Europe Neurorehabilitation Devices Market Breakdown, by Application
- 10.2.1.1.3 UK: Europe Neurorehabilitation Devices Market Breakdown, by End User
- 10.2.1.2 Germany: Europe Neurorehabilitation Devices Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.2.1 Germany: Europe Neurorehabilitation Devices Market Breakdown, by Product Type
- 10.2.1.2.2 Germany: Europe Neurorehabilitation Devices Market Breakdown, by Application
- 10.2.1.2.3 Germany: Europe Neurorehabilitation Devices Market Breakdown, by End User
- 10.2.1.3 France: Europe Neurorehabilitation Devices Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.3.1 France: Europe Neurorehabilitation Devices Market Breakdown, by Product Type
- 10.2.1.3.2 France: Europe Neurorehabilitation Devices Market Breakdown, by Application
- 10.2.1.3.3 France: Europe Neurorehabilitation Devices Market Breakdown, by End User
- 10.2.1.4 Russia: Europe Neurorehabilitation Devices Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.4.1 Russia: Europe Neurorehabilitation Devices Market Breakdown, by Product Type
- 10.2.1.4.2 Russia: Europe Neurorehabilitation Devices Market Breakdown, by Application
- 10.2.1.4.3 Russia: Europe Neurorehabilitation Devices Market Breakdown, by End User
- 10.2.1.5 Italy: Europe Neurorehabilitation Devices Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.5.1 Italy: Europe Neurorehabilitation Devices Market Breakdown, by Product Type
- 10.2.1.5.2 Italy: Europe Neurorehabilitation Devices Market Breakdown, by Application
- 10.2.1.5.3 Italy: Europe Neurorehabilitation Devices Market Breakdown, by End User
- 10.2.1.6 Rest of Europe: Europe Neurorehabilitation Devices Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.6.1 Rest of Europe: Europe Neurorehabilitation Devices Market Breakdown, by Product Type
- 10.2.1.6.2 Rest of Europe: Europe Neurorehabilitation Devices Market Breakdown, by Application
- 10.2.1.6.3 Rest of Europe: Europe Neurorehabilitation Devices Market Breakdown, by End User
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 Abbott Laboratories
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 BIONIK
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 BioXtreme Ltd
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Blackrock Microsystems Inc
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Ekso Bionics Holdings Inc
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 EMOTIV
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Hocoma AG
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Medtronic Plc
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Renishaw Plc
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Tyromotion GmbH
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations
Access the Full E Market Report
Get segment-level forecasts, regional estimates, competitive benchmarking, company profiles and downloadable Excel datasets.